Skip to main content
. 2016 Feb 18;5(7):1136045. doi: 10.1080/2162402X.2015.1136045

Figure 4.

Figure 4.

CTLA-4 blockade and markers associated with clinical response. Patients were subdivided in two groups, DC (gray line and dots) and NR (black line and dots). Clinical benefit is associated with a more marked increase of memory subsets (A and B) and of eomes expressing CD8+ T cells (C). *for p < 0.05, ** for p < 0.01